LATOYA AJILEYE: Open Payments
NPI 1386154540 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 58 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $800 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 12 | $389 |
| AstraZeneca Pharmaceuticals LP | 9 | $186 |
| Novo Nordisk Inc | 8 | $184 |
| Astellas Pharma US Inc | 3 | $178 |
| Lilly USA, LLC | 4 | $139 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| SANOFI-AVENTIS U.S. LLC | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Exact Sciences Corporation | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
Products named: APRETUDE, JARDIANCE, Veozah, Wegovy, FARXIGA, SHINGRIX, TZIELD, BREZTRI.
Industry payments across GA — which companies pay providers there.
